Concatemers to re-investigate the role of α5 in α4β2 nicotinic receptors
- 29 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 78 (3), 1051-1064
- https://doi.org/10.1007/s00018-020-03558-z
Abstract
Nicotinic acetylcholine receptors (nAChRs) are pentameric ion channels expressed in the central nervous systems. nAChRs containing the α4, β2 and α5 subunits are specifically involved in addictive processes, but their functional architecture is poorly understood due to the intricacy of assembly of these subunits. Here we constrained the subunit assembly by designing fully concatenated human α4β2 and α4β2α5 receptors and characterized their properties by two-electrodes voltage–clamp electrophysiology in Xenopus oocytes. We found that α5-containing nAChRs are irreversibly blocked by methanethiosulfonate (MTS) reagents through a covalent reaction with a cysteine present only in α5. MTS-block experiments establish that the concatemers are expressed in intact form at the oocyte surface, but that reconstitution of nAChRs from loose subunits show inefficient and highly variable assembly of α5 with α4 and β2. Mutational analysis shows that the concatemers assemble both in clockwise and anticlockwise orientations, and that α5 does not contribute to ACh binding from its principal (+) site. Reinvestigation of suspected α5-ligands such as galantamine show no specific effect on α5-containing concatemers. Analysis of the α5-D398N mutation that is linked to smoking and lung cancer shows no significant effect on the electrophysiological function, suggesting that its effect might arise from alteration of other cellular processes. The concatemeric strategy provides a well-characterized platform for mechanistic analysis and screening of human α5-specific ligands.Keywords
Funding Information
- European Research Council (788974)
- Fondation pour la Recherche Médicale (DEQ20140329497)
- Fondation ARC pour la Recherche sur le Cancer
- H2020 Marie Skłodowska-Curie Actions (659371)
This publication has 55 references indexed in Scilit:
- The additional ACh binding site at the α4(+)/α4(−) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitizationBritish Journal of Pharmacology, 2013
- Additional Acetylcholine (ACh) Binding Site at α4/α4 Interface of (α4β2)2α4 Nicotinic Receptor Influences Agonist SensitivityJournal of Biological Chemistry, 2011
- Functional Characterization of the α5(Asn398) Variant Associated with Risk for Nicotine Dependence in the α3β4α5 Nicotinic ReceptorPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2011
- Desensitization of α7 Nicotinic Receptor Is Governed by Coupling Strength Relative to Gate TightnessPublished by Elsevier BV ,2011
- Habenular α5 nicotinic receptor subunit signalling controls nicotine intakeNature, 2011
- Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR FunctionPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2010
- Working with OpusXpress: Methods for high volume oocyte experimentsMethods, 2010
- Improved prediction of protein side‐chain conformations with SCWRL4Proteins-Structure Function and Bioinformatics, 2009
- Pentameric concatenated (α4)2(β2)3 and (α4)3(β2)2 nicotinic acetylcholine receptors: subunit arrangement determines functional expressionBritish Journal of Pharmacology, 2009
- Nicotine binding to brain receptors requires a strong cation–π interactionNature, 2009